Navigation thread
Clinical Pharmacology Service
Research - Clinical Pharmacology Service
The Clinical Pharmacology Department’s research activity is carried out through the Interdisciplinary Research Groups Area of the August Pi i Sunyer Biomedical Research Institute (IDIBAPS).
The Department’s research activities focus on the following lines of research:
- Clinical research ethics. This line of research falls within the scope of research in research, that is the pursuit of quality and the scope and context of application of current ethical principles in clinical research projects. It is carried out through group studies and as support for researchers provided by the Technical Secretariat of the CEIm, which is part of the Technical Secretariat for Research Support (Drug Area).
- Clinical trials, design, methodology, and statistical support for clinical research. This line focuses on optimizing the methodological and statistical support provided to clinical research to enhance it, both in an academic setting and in studies sponsored by the pharmaceutical industry. It is carried out within the framework of the Clinical Trials Unit and the Medical Statistics Platform at IDIBAPS.
- Coordination of multinational projects and research networks (ECRIN/SCReN). The team collaborates actively in national clinical research networks, such as SCReN, or international ones, such as ECRIN, to carry out multicentre clinical research on a national and international scale.
- Pharmacovigilance. Within the multidisciplinary Pharmacovigilance group, the team conducts research on the molecular and pathophysiological mechanisms of adverse drug reactions, as well as on the implementation of active pharmacovigilance systems that optimize the detection of adverse drug reactions in a real-world clinical setting.
- Pharmacogenetics and pharmacogenomics. The team collaborates with the Pharmacology Unit at the University of Barcelona, which conducts studies to link genetics with drug activity and response.
Finally, the team participates in trial monitoring committees known as Data and Safety Monitoring Boards (DSMB), which are responsible for monitoring the progress of trials externally and deciding whether to continue them over time.
